The Genesis Oncology Trust funds a broad range of cancer-control research, training and education.
Our charitable purpose:
- To promote research in New Zealand into the detection, diagnosis and treatment of all forms of cancer and to provide associated training for health professionals;
- To promote the provision of palliative care;
- To assist hospitals and associated health care providers with the provision of facilities in relation to oncology; and
- To promote such other charitable purposes as the trustees may decide.
The Trust was set up in 2002 by Genesis Energy to support the company’s ongoing commitment to the community and to contribute in a positive way to a major health problem in New Zealand.
The Genesis Oncology Trust makes a significant contribution by funding carefully selected projects that contribute to a wider body of research. Most advances in the area of medical research are made by acquiring new pieces of knowledge and fitting these into the leading edge of existing knowledge. Considerable investment has also been made in the professional development of individuals with the potential to advance the field of cancer control and palliative care.
The Trust is funded through one-off donations, the ongoing generosity of Genesis Energy customers who donate to the Trust through their monthly energy bill and endowment grants from Genesis Energy.
It is the Trust’s policy that 100% of all money donated by its donors is applied to the fight against cancer. All administrative costs are covered directly by Genesis Energy.
The grant round process is managed by the Program Manager, Douglas Ormrod, PhD. Douglas is a trained experimental pathologist with over 30 years research experience. His primary task is to manage the research rounds; seeking and processing applications; garnering local and international reviews for research proposals and acting as a liaison between the applicants and the Genesis Oncology Trust assessment committee. He also oversees the disbursement of grants and is responsible for producing the Genesis Oncology Trust New Hope newsletter and related publications.